Rhinomed Ltd. | Cash Flow

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,534.60
5,317.00
5,998.50
4,441.60
-
Depreciation, Depletion & Amortization
240.70
451.00
527.30
470.20
-
Other Funds
775.00
97.40
142.00
659.70
-
Funds from Operations
2,518.90
4,768.50
5,329.20
3,311.70
3,845.30
Changes in Working Capital
312.40
295.80
795.80
315.40
-
Net Operating Cash Flow
2,206.50
4,472.70
6,125.00
2,996.30
3,845.30
Capital Expenditures
248.90
333.40
20.00
4.70
11.80
Purchase/Sale of Investments
408.40
-
310.10
51.50
-
Net Investing Cash Flow
107.50
333.40
394.60
46.80
11.80
Issuance/Reduction of Debt, Net
52.40
-
-
-
-
Net Financing Cash Flow
3,227.70
4,722.80
6,992.10
2,015.70
3,431.40
Net Change in Cash
1,128.70
83.20
1,244.10
945.90
403.80
Free Cash Flow
2,283.40
4,806.10
6,145.00
3,001.00
3,857.20
Other Sources
-
-
104.50
-
-
Change in Capital Stock
3,280.10
4,722.80
6,992.10
2,015.70
3,431.40
Exchange Rate Effect
-
-
17.60
12.10
22.00
Other Uses
52.00
-
-
-
-

About Rhinomed

View Profile
Address
97 Green Street
Cremorne Victoria (VIC) 3121
Australia
Employees -
Website http://www.rhinomed.global
Updated 07/08/2019
Rhinomed Ltd. is medical technology company, which engages in the identification, acquisition, and commercialization of stage therapeutic delivery technologies. It operates through Turbine and Mute technology. The Turbine technology, a nasal dilator designed to assist breathe during aerobic exercise.